Hence, on the one hand, it could be hypothesized that CSF levels of CRP in AD are a consequence of decreased blood levels associated with the ApoE4 genotype, which is simultaneously the strongest genetic risk factor for AD. The gene discussed is APOE; the disease is Alzheimer disease.